SEC Form 4 · accession 0001209191-15-017920
CEPHEID · CPHD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David H Persing
Officer — EVP, Chief Med/Tech Officer · Director
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037760
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | M | 5,000 | $8.43 | A | 9,687 | D | |
| Common StockF1 | Feb 20, 2015 | S | 5,000 | $58.6022 | D | 4,687 | D | |
| Common Stock | Feb 20, 2015 | M | 5,000 | $7.38 | A | 9,687 | D | |
| Common StockF1 | Feb 20, 2015 | S | 5,000 | $58.6022 | D | 4,687 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $8.43 | Feb 20, 2015 | M | 5,000 | D | — | Apr 28, 2016 | Common Stock | 5,000 | 0 | D |
| Non-qualified Stock Option (Right to Buy)F2 | $7.38 | Feb 20, 2015 | M | 5,000 | D | — | Aug 29, 2015 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
- F225% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.